Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anja Seubert

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 2015
MF59 Mediates Its B Cell Adjuvanticity by Promoting T Follicular Helper Cells and Thus Germinal Center Responses in Adult and Early LifeBeatris Mastelic Gavillet, Christiane S Eberhardt, Floriane Auderset, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 11, 2013
The adjuvant MF59 induces ATP release from muscle that potentiates response to vaccinationMaria Vono, Marianna Taccone, Paola Caccin, et al.
Science Translational Medicine|June 9, 2017
Vaccine priming is restricted to draining lymph nodes and controlled by adjuvant-mediated antigen uptakeFrank Liang, Gustaf Lindgren, Kerrie J Sandgren, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 22, 2011
Adjuvanticity of the oil-in-water emulsion MF59 is independent of Nlrp3 inflammasome but requires the adaptor protein MyD88Anja Seubert, Samuele Calabro, Laura Santini, et al.
Scientific Reports|December 1, 2016
Staphylococcus aureus-dependent septic arthritis in murine knee joints: local immune response and beneficial effects of vaccinationAlessia Corrado, Paolo Donato, Silvia Maccari, et al.
Human Vaccines & Immunotherapeutics|November 28, 2017
A phase I, randomized, controlled, dose-ranging study of investigational acellular pertussis (aP) and reduced tetanus-diphtheria-acellular pertussis (TdaP) booster vaccines in adultsGeert Leroux-Roels, Maria Lattanzi, Claudia Dovali Solis, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 17, 2014
A cationic nanoemulsion for the delivery of next-generation RNA vaccinesLuis A Brito, Michelle Chan, Christine A Shaw, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 2015
MF59 Mediates Its B Cell Adjuvanticity by Promoting T Follicular Helper Cells and Thus Germinal Center Responses in Adult and Early LifeBeatris Mastelic Gavillet, Christiane S Eberhardt, Floriane Auderset, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 11, 2013
The adjuvant MF59 induces ATP release from muscle that potentiates response to vaccinationMaria Vono, Marianna Taccone, Paola Caccin, et al.
Science Translational Medicine|June 9, 2017
Vaccine priming is restricted to draining lymph nodes and controlled by adjuvant-mediated antigen uptakeFrank Liang, Gustaf Lindgren, Kerrie J Sandgren, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 22, 2011
Adjuvanticity of the oil-in-water emulsion MF59 is independent of Nlrp3 inflammasome but requires the adaptor protein MyD88Anja Seubert, Samuele Calabro, Laura Santini, et al.
Scientific Reports|December 1, 2016
Staphylococcus aureus-dependent septic arthritis in murine knee joints: local immune response and beneficial effects of vaccinationAlessia Corrado, Paolo Donato, Silvia Maccari, et al.
Human Vaccines & Immunotherapeutics|November 28, 2017
A phase I, randomized, controlled, dose-ranging study of investigational acellular pertussis (aP) and reduced tetanus-diphtheria-acellular pertussis (TdaP) booster vaccines in adultsGeert Leroux-Roels, Maria Lattanzi, Claudia Dovali Solis, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 17, 2014
A cationic nanoemulsion for the delivery of next-generation RNA vaccinesLuis A Brito, Michelle Chan, Christine A Shaw, et al.
Pageof 3